Furthermore, the biological impact of MPZL1 in diverse tumors, including ovarian, colorectal, and bladder cancers, has been investigated and corroborated (64–66), highlighting its promotional influence on tumor progression. The gene discussed is MPZL1; the disease is urinary bladder cancer.